APO Research
Talk to an analyst

APO RESEARCH · REPORT

ELISA Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global ELISA Testing Service Market Outlook and Growth Opportunities 2026

3 May 2026190 pages

Choose your research edition.

Industry ResearchELISA Testing Service Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal ELISA Testing Service Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal ELISA Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal ELISA Testing Service Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal ELISA Testing Service Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global ELISA Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for ELISA Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for ELISA Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for ELISA Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the ELISA Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the ELISA Testing Service market include Boster Bio, RayBiotech, R&D Systems, Inc, ELISA Technologies, Inc., Cellular Technology Limited, Virology Research Services Ltd, Chimera Biotec, NorthEast BioLab and Sino Biological, Inc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global ELISA Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of ELISA Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents ELISA Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global ELISA Testing Service market.

ELISA Testing Service Segment by Company

Boster Bio

RayBiotech

R&D Systems, Inc

ELISA Technologies, Inc.

Cellular Technology Limited

Virology Research Services Ltd

Chimera Biotec

NorthEast BioLab

Sino Biological, Inc

Kaneka Eurogentec S.A.

Prove Laboratory Services

KCAS Bio

BioCat GmbH

Aviva Systems Biology Corporation

Eve Technologies

Boster Biological Technology

Bio-Techne

Precision Medicine Group, LLC

ACROBiosystems

mabtech

Cellular Technology Limited（immunospot）

Pestka Biomedical Laboratories, Inc

ProteoGenix

Kaneka Eurogentec S.A

ELISA Testing Service Segment by Type

ELISA Test Development

ELISA Test Validation

Others

ELISA Testing Service Segment by Application

Disease Diagnosis

Vaccine Effectiveness Evaluation

Drug Development

Allergen Testing

Others

ELISA Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global ELISA Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the ELISA Testing Service key companies, revenue, market share, and recent developments.

3. To split the ELISA Testing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions ELISA Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify ELISA Testing Service significant trends, drivers, influence factors in global and regions.

6. To analyze ELISA Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ELISA Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of ELISA Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ELISA Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global ELISA Testing Service industry.

Chapter 3: Detailed analysis of ELISA Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of ELISA Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of ELISA Testing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. ELISA Testing Service Industry Trends Table 2. ELISA Testing Service Industry Drivers Table 3. ELISA Testing Service Industry Opportunities and Challenges Table 4. ELISA Testing Service Industry Restraints Table 5. Global ELISA Testing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global ELISA Testing Service Revenue Share by Company (2021-2026) Table 7. Global ELISA Testing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global ELISA Testing Service Key Company Manufacturing Base & Headquarters Table 9. Global ELISA Testing Service Company, Product Type & Application Table 10. Global ELISA Testing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global ELISA Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of ELISA Test Development Table 15. Significant Companies of ELISA Test Validation Table 16. Significant Companies of Others Table 17. Global ELISA Testing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global ELISA Testing Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global ELISA Testing Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global ELISA Testing Service Sales Value Share by Type (2021-2026) Table 21. Global ELISA Testing Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Disease Diagnosis Table 23. Significant Companies of Vaccine Effectiveness Evaluation Table 24. Significant Companies of Drug Development Table 25. Significant Companies of Allergen Testing Table 26. Significant Companies of Others Table 27. Global ELISA Testing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global ELISA Testing Service Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global ELISA Testing Service Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global ELISA Testing Service Sales Value Share by Application (2021-2026) Table 31. Global ELISA Testing Service Sales Value Share by Application (2027-2032) Table 32. Global ELISA Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global ELISA Testing Service Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global ELISA Testing Service Sales Value Share by Region (2021-2026) Table 35. Global ELISA Testing Service Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global ELISA Testing Service Sales Value Share by Region (2027-2032) Table 37. Global ELISA Testing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global ELISA Testing Service Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global ELISA Testing Service Sales Value Market Share by Country (2021-2026) Table 40. Global ELISA Testing Service Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global ELISA Testing Service Sales Value Market Share by Country (2027-2032) Table 42. Boster Bio Company Information Table 43. Boster Bio Business Overview Table 44. Boster Bio ELISA Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Boster Bio ELISA Testing Service Product Portfolio Table 46. Boster Bio Recent Development Table 47. RayBiotech Company Information Table 48. RayBiotech Business Overview Table 49. RayBiotech ELISA Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. RayBiotech ELISA Testing Service Product Portfolio Table 51. RayBiotech Recent Development Table 52. R&D Systems, Inc Company Information Table 53. R&D Systems, Inc Business Overview Table 54. R&D Systems, Inc ELISA Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. R&D Systems, Inc ELISA Testing Service Product Portfolio Table 56. R&D Systems, Inc Recent Development Table 57. ELISA Technologies, Inc. Company Information Table 58. ELISA Technologies, Inc. Business Overview Table 59. ELISA Technologies, Inc. ELISA Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. ELISA Technologies, Inc. ELISA Testing Service Product Portfolio Table 61. ELISA Technologies, Inc. Recent Development Table 62. Cellular Technology Limited Company Information Table 63. Cellular Technology Limited Business Overview Table 64. Cellular Technology Limited ELISA Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Cellular Technology Limited ELISA Testing Service Product Portfolio Table 66. Cellular Technology Limited Recent Development Table 67. Virology Research Services Ltd Company Information Table 68. Virology Research Services Ltd Business Overview Table 69. Virology Research Services Ltd ELISA Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Virology Research Services Ltd ELISA Testing Service Product Portfolio Table 71. Virology Research Services Ltd Recent Development Table 72. Chimera Biotec Company Information Table 73. Chimera Biotec Business Overview Table 74. Chimera Biotec ELISA Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Chimera Biotec ELISA Testing Service Product Portfolio Table 76. Chimera Biotec Recent Development Table 77. NorthEast BioLab Company Information Table 78. NorthEast BioLab Business Overview Table 79. NorthEast BioLab ELISA Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. NorthEast BioLab ELISA Testing Service Product Portfolio Table 81. NorthEast BioLab Recent Development Table 82. Sino Biological, Inc Company Information Table 83. Sino Biological, Inc Business Overview Table 84. Sino Biological, Inc ELISA Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Sino Biological, Inc ELISA Testing Service Product Portfolio Table 86. Sino Biological, Inc Recent Development Table 87. Kaneka Eurogentec S.A. Company Information Table 88. Kaneka Eurogentec S.A. Business Overview Table 89. Kaneka Eurogentec S.A. ELISA Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Kaneka Eurogentec S.A. ELISA Testing Service Product Portfolio Table 91. Kaneka Eurogentec S.A. Recent Development Table 92. Prove Laboratory Services Company Information Table 93. Prove Laboratory Services Business Overview Table 94. Prove Laboratory Services ELISA Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Prove Laboratory Services ELISA Testing Service Product Portfolio Table 96. Prove Laboratory Services Recent Development Table 97. KCAS Bio Company Information Table 98. KCAS Bio Business Overview Table 99. KCAS Bio ELISA Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. KCAS Bio ELISA Testing Service Product Portfolio Table 101. KCAS Bio Recent Development Table 102. BioCat GmbH Company Information Table 103. BioCat GmbH Business Overview Table 104. BioCat GmbH ELISA Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. BioCat GmbH ELISA Testing Service Product Portfolio Table 106. BioCat GmbH Recent Development Table 107. Aviva Systems Biology Corporation Company Information Table 108. Aviva Systems Biology Corporation Business Overview Table 109. Aviva Systems Biology Corporation ELISA Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Aviva Systems Biology Corporation ELISA Testing Service Product Portfolio Table 111. Aviva Systems Biology Corporation Recent Development Table 112. Eve Technologies Company Information Table 113. Eve Technologies Business Overview Table 114. Eve Technologies ELISA Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Eve Technologies ELISA Testing Service Product Portfolio Table 116. Eve Technologies Recent Development Table 117. Boster Biological Technology Company Information Table 118. Boster Biological Technology Business Overview Table 119. Boster Biological Technology ELISA Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Boster Biological Technology ELISA Testing Service Product Portfolio Table 121. Boster Biological Technology Recent Development Table 122. Bio-Techne Company Information Table 123. Bio-Techne Business Overview Table 124. Bio-Techne ELISA Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Bio-Techne ELISA Testing Service Product Portfolio Table 126. Bio-Techne Recent Development Table 127. Precision Medicine Group, LLC Company Information Table 128. Precision Medicine Group, LLC Business Overview Table 129. Precision Medicine Group, LLC ELISA Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Precision Medicine Group, LLC ELISA Testing Service Product Portfolio Table 131. Precision Medicine Group, LLC Recent Development Table 132. ACROBiosystems Company Information Table 133. ACROBiosystems Business Overview Table 134. ACROBiosystems ELISA Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. ACROBiosystems ELISA Testing Service Product Portfolio Table 136. ACROBiosystems Recent Development Table 137. mabtech Company Information Table 138. mabtech Business Overview Table 139. mabtech ELISA Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. mabtech ELISA Testing Service Product Portfolio Table 141. mabtech Recent Development Table 142. Cellular Technology Limited（immunospot） Company Information Table 143. Cellular Technology Limited（immunospot） Business Overview Table 144. Cellular Technology Limited（immunospot） ELISA Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Cellular Technology Limited（immunospot） ELISA Testing Service Product Portfolio Table 146. Cellular Technology Limited（immunospot） Recent Development Table 147. Pestka Biomedical Laboratories, Inc Company Information Table 148. Pestka Biomedical Laboratories, Inc Business Overview Table 149. Pestka Biomedical Laboratories, Inc ELISA Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Pestka Biomedical Laboratories, Inc ELISA Testing Service Product Portfolio Table 151. Pestka Biomedical Laboratories, Inc Recent Development Table 152. ProteoGenix Company Information Table 153. ProteoGenix Business Overview Table 154. ProteoGenix ELISA Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. ProteoGenix ELISA Testing Service Product Portfolio Table 156. ProteoGenix Recent Development Table 157. Kaneka Eurogentec S.A Company Information Table 158. Kaneka Eurogentec S.A Business Overview Table 159. Kaneka Eurogentec S.A ELISA Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Kaneka Eurogentec S.A ELISA Testing Service Product Portfolio Table 161. Kaneka Eurogentec S.A Recent Development Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. ELISA Testing Service Product Image Figure 2. Global ELISA Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global ELISA Testing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global ELISA Testing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. ELISA Test Development Image Figure 8. ELISA Test Validation Image Figure 9. Others Image Figure 10. Global ELISA Testing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global ELISA Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global ELISA Testing Service Sales Value Share by Type (2021-2032) Figure 13. Disease Diagnosis Image Figure 14. Vaccine Effectiveness Evaluation Image Figure 15. Drug Development Image Figure 16. Allergen Testing Image Figure 17. Others Image Figure 18. Global ELISA Testing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global ELISA Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global ELISA Testing Service Sales Value Share by Application (2021-2032) Figure 21. Global ELISA Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global ELISA Testing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America ELISA Testing Service Sales Value (2021-2032) & (US$ Million) Figure 24. North America ELISA Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe ELISA Testing Service Sales Value (2021-2032) & (US$ Million) Figure 26. Europe ELISA Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific ELISA Testing Service Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific ELISA Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America ELISA Testing Service Sales Value (2021-2032) & (US$ Million) Figure 30. South America ELISA Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa ELISA Testing Service Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa ELISA Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt ELISA Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt ELISA Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt ELISA Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • ELISA Test Development
  • ELISA Test Validation
  • Others
Applications
  • Disease Diagnosis
  • Vaccine Effectiveness Evaluation
  • Drug Development
  • Allergen Testing
  • Others
Companies covered
  • Boster Bio
  • RayBiotech
  • R&D Systems, Inc
  • ELISA Technologies, Inc.
  • Cellular Technology Limited
  • Virology Research Services Ltd
  • Chimera Biotec
  • NorthEast BioLab
  • Sino Biological, Inc
  • Kaneka Eurogentec S.A.
  • Prove Laboratory Services
  • KCAS Bio
  • BioCat GmbH
  • Aviva Systems Biology Corporation
  • Eve Technologies
  • Boster Biological Technology
  • Bio-Techne
  • Precision Medicine Group, LLC
  • ACROBiosystems
  • mabtech
  • Cellular Technology Limited（immunospot）
  • Pestka Biomedical Laboratories, Inc
  • ProteoGenix
  • Kaneka Eurogentec S.A

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global ELISA Testing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global ELISA Testing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 ELISA Testing Service Market Dynamics
  1. 2.1 ELISA Testing Service Industry Trends
  2. 2.2 ELISA Testing Service Industry Drivers
  3. 2.3 ELISA Testing Service Industry Opportunities and Challenges
  4. 2.4 ELISA Testing Service Industry Restraints
3 ELISA Testing Service Market by Company
  1. 3.1 Global ELISA Testing Service Company Revenue Ranking in 2025
  2. 3.2 Global ELISA Testing Service Revenue by Company (2021-2026)
  3. 3.3 Global ELISA Testing Service Company Ranking (2024-2026)
  4. 3.4 Global ELISA Testing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global ELISA Testing Service Company Product Type and Application
  6. 3.6 Global ELISA Testing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global ELISA Testing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 ELISA Testing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 ELISA Testing Service Market by Type
  1. 4.1 ELISA Testing Service Type Introduction
  2. 4.1.1 ELISA Test Development
  3. 4.1.2 ELISA Test Validation
  4. 4.1.3 Others
  5. 4.2 Global ELISA Testing Service Sales Value by Type
  6. 4.2.1 Global ELISA Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global ELISA Testing Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global ELISA Testing Service Sales Value Share by Type (2021-2032)
5 ELISA Testing Service Market by Application
  1. 5.1 ELISA Testing Service Application Introduction
  2. 5.1.1 Disease Diagnosis
  3. 5.1.2 Vaccine Effectiveness Evaluation
  4. 5.1.3 Drug Development
  5. 5.1.4 Allergen Testing
  6. 5.1.5 Others
  7. 5.2 Global ELISA Testing Service Sales Value by Application
  8. 5.2.1 Global ELISA Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global ELISA Testing Service Sales Value by Application (2021-2032)
  10. 5.2.3 Global ELISA Testing Service Sales Value Share by Application (2021-2032)
6 ELISA Testing Service Regional Value Analysis
  1. 6.1 Global ELISA Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global ELISA Testing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global ELISA Testing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global ELISA Testing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America ELISA Testing Service Sales Value (2021-2032)
  7. 6.3.2 North America ELISA Testing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe ELISA Testing Service Sales Value (2021-2032)
  10. 6.4.2 Europe ELISA Testing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific ELISA Testing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific ELISA Testing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America ELISA Testing Service Sales Value (2021-2032)
  16. 6.6.2 South America ELISA Testing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa ELISA Testing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa ELISA Testing Service Sales Value Share by Country, 2025 VS 2032
7 ELISA Testing Service Country-level Value Analysis
  1. 7.1 Global ELISA Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global ELISA Testing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global ELISA Testing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global ELISA Testing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA ELISA Testing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada ELISA Testing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico ELISA Testing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany ELISA Testing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France ELISA Testing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. ELISA Testing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy ELISA Testing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain ELISA Testing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia ELISA Testing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands ELISA Testing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries ELISA Testing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China ELISA Testing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan ELISA Testing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea ELISA Testing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India ELISA Testing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia ELISA Testing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia ELISA Testing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil ELISA Testing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina ELISA Testing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile ELISA Testing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia ELISA Testing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru ELISA Testing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia ELISA Testing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel ELISA Testing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE ELISA Testing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey ELISA Testing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran ELISA Testing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt ELISA Testing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt ELISA Testing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt ELISA Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boster Bio
  2. 8.1.1 Boster Bio Company Information
  3. 8.1.2 Boster Bio Business Overview
  4. 8.1.3 Boster Bio ELISA Testing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boster Bio ELISA Testing Service Product Portfolio
  6. 8.1.5 Boster Bio Recent Developments
  7. 8.2 RayBiotech
  8. 8.2.1 RayBiotech Company Information
  9. 8.2.2 RayBiotech Business Overview
  10. 8.2.3 RayBiotech ELISA Testing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 RayBiotech ELISA Testing Service Product Portfolio
  12. 8.2.5 RayBiotech Recent Developments
  13. 8.3 R&D Systems, Inc
  14. 8.3.1 R&D Systems, Inc Company Information
  15. 8.3.2 R&D Systems, Inc Business Overview
  16. 8.3.3 R&D Systems, Inc ELISA Testing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 R&D Systems, Inc ELISA Testing Service Product Portfolio
  18. 8.3.5 R&D Systems, Inc Recent Developments
  19. 8.4 ELISA Technologies, Inc.
  20. 8.4.1 ELISA Technologies, Inc. Company Information
  21. 8.4.2 ELISA Technologies, Inc. Business Overview
  22. 8.4.3 ELISA Technologies, Inc. ELISA Testing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ELISA Technologies, Inc. ELISA Testing Service Product Portfolio
  24. 8.4.5 ELISA Technologies, Inc. Recent Developments
  25. 8.5 Cellular Technology Limited
  26. 8.5.1 Cellular Technology Limited Company Information
  27. 8.5.2 Cellular Technology Limited Business Overview
  28. 8.5.3 Cellular Technology Limited ELISA Testing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cellular Technology Limited ELISA Testing Service Product Portfolio
  30. 8.5.5 Cellular Technology Limited Recent Developments
  31. 8.6 Virology Research Services Ltd
  32. 8.6.1 Virology Research Services Ltd Company Information
  33. 8.6.2 Virology Research Services Ltd Business Overview
  34. 8.6.3 Virology Research Services Ltd ELISA Testing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Virology Research Services Ltd ELISA Testing Service Product Portfolio
  36. 8.6.5 Virology Research Services Ltd Recent Developments
  37. 8.7 Chimera Biotec
  38. 8.7.1 Chimera Biotec Company Information
  39. 8.7.2 Chimera Biotec Business Overview
  40. 8.7.3 Chimera Biotec ELISA Testing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Chimera Biotec ELISA Testing Service Product Portfolio
  42. 8.7.5 Chimera Biotec Recent Developments
  43. 8.8 NorthEast BioLab
  44. 8.8.1 NorthEast BioLab Company Information
  45. 8.8.2 NorthEast BioLab Business Overview
  46. 8.8.3 NorthEast BioLab ELISA Testing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 NorthEast BioLab ELISA Testing Service Product Portfolio
  48. 8.8.5 NorthEast BioLab Recent Developments
  49. 8.9 Sino Biological, Inc
  50. 8.9.1 Sino Biological, Inc Company Information
  51. 8.9.2 Sino Biological, Inc Business Overview
  52. 8.9.3 Sino Biological, Inc ELISA Testing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sino Biological, Inc ELISA Testing Service Product Portfolio
  54. 8.9.5 Sino Biological, Inc Recent Developments
  55. 8.10 Kaneka Eurogentec S.A.
  56. 8.10.1 Kaneka Eurogentec S.A. Company Information
  57. 8.10.2 Kaneka Eurogentec S.A. Business Overview
  58. 8.10.3 Kaneka Eurogentec S.A. ELISA Testing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kaneka Eurogentec S.A. ELISA Testing Service Product Portfolio
  60. 8.10.5 Kaneka Eurogentec S.A. Recent Developments
  61. 8.11 Prove Laboratory Services
  62. 8.11.1 Prove Laboratory Services Company Information
  63. 8.11.2 Prove Laboratory Services Business Overview
  64. 8.11.3 Prove Laboratory Services ELISA Testing Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Prove Laboratory Services ELISA Testing Service Product Portfolio
  66. 8.11.5 Prove Laboratory Services Recent Developments
  67. 8.12 KCAS Bio
  68. 8.12.1 KCAS Bio Company Information
  69. 8.12.2 KCAS Bio Business Overview
  70. 8.12.3 KCAS Bio ELISA Testing Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 KCAS Bio ELISA Testing Service Product Portfolio
  72. 8.12.5 KCAS Bio Recent Developments
  73. 8.13 BioCat GmbH
  74. 8.13.1 BioCat GmbH Company Information
  75. 8.13.2 BioCat GmbH Business Overview
  76. 8.13.3 BioCat GmbH ELISA Testing Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 BioCat GmbH ELISA Testing Service Product Portfolio
  78. 8.13.5 BioCat GmbH Recent Developments
  79. 8.14 Aviva Systems Biology Corporation
  80. 8.14.1 Aviva Systems Biology Corporation Company Information
  81. 8.14.2 Aviva Systems Biology Corporation Business Overview
  82. 8.14.3 Aviva Systems Biology Corporation ELISA Testing Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aviva Systems Biology Corporation ELISA Testing Service Product Portfolio
  84. 8.14.5 Aviva Systems Biology Corporation Recent Developments
  85. 8.15 Eve Technologies
  86. 8.15.1 Eve Technologies Company Information
  87. 8.15.2 Eve Technologies Business Overview
  88. 8.15.3 Eve Technologies ELISA Testing Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Eve Technologies ELISA Testing Service Product Portfolio
  90. 8.15.5 Eve Technologies Recent Developments
  91. 8.16 Boster Biological Technology
  92. 8.16.1 Boster Biological Technology Company Information
  93. 8.16.2 Boster Biological Technology Business Overview
  94. 8.16.3 Boster Biological Technology ELISA Testing Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Boster Biological Technology ELISA Testing Service Product Portfolio
  96. 8.16.5 Boster Biological Technology Recent Developments
  97. 8.17 Bio-Techne
  98. 8.17.1 Bio-Techne Company Information
  99. 8.17.2 Bio-Techne Business Overview
  100. 8.17.3 Bio-Techne ELISA Testing Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bio-Techne ELISA Testing Service Product Portfolio
  102. 8.17.5 Bio-Techne Recent Developments
  103. 8.18 Precision Medicine Group, LLC
  104. 8.18.1 Precision Medicine Group, LLC Company Information
  105. 8.18.2 Precision Medicine Group, LLC Business Overview
  106. 8.18.3 Precision Medicine Group, LLC ELISA Testing Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Precision Medicine Group, LLC ELISA Testing Service Product Portfolio
  108. 8.18.5 Precision Medicine Group, LLC Recent Developments
  109. 8.19 ACROBiosystems
  110. 8.19.1 ACROBiosystems Company Information
  111. 8.19.2 ACROBiosystems Business Overview
  112. 8.19.3 ACROBiosystems ELISA Testing Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 ACROBiosystems ELISA Testing Service Product Portfolio
  114. 8.19.5 ACROBiosystems Recent Developments
  115. 8.20 mabtech
  116. 8.20.1 mabtech Company Information
  117. 8.20.2 mabtech Business Overview
  118. 8.20.3 mabtech ELISA Testing Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 mabtech ELISA Testing Service Product Portfolio
  120. 8.20.5 mabtech Recent Developments
  121. 8.21 Cellular Technology Limited（immunospot）
  122. 8.21.1 Cellular Technology Limited（immunospot） Company Information
  123. 8.21.2 Cellular Technology Limited（immunospot） Business Overview
  124. 8.21.3 Cellular Technology Limited（immunospot） ELISA Testing Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Cellular Technology Limited（immunospot） ELISA Testing Service Product Portfolio
  126. 8.21.5 Cellular Technology Limited（immunospot） Recent Developments
  127. 8.22 Pestka Biomedical Laboratories, Inc
  128. 8.22.1 Pestka Biomedical Laboratories, Inc Company Information
  129. 8.22.2 Pestka Biomedical Laboratories, Inc Business Overview
  130. 8.22.3 Pestka Biomedical Laboratories, Inc ELISA Testing Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Pestka Biomedical Laboratories, Inc ELISA Testing Service Product Portfolio
  132. 8.22.5 Pestka Biomedical Laboratories, Inc Recent Developments
  133. 8.23 ProteoGenix
  134. 8.23.1 ProteoGenix Company Information
  135. 8.23.2 ProteoGenix Business Overview
  136. 8.23.3 ProteoGenix ELISA Testing Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 ProteoGenix ELISA Testing Service Product Portfolio
  138. 8.23.5 ProteoGenix Recent Developments
  139. 8.24 Kaneka Eurogentec S.A
  140. 8.24.1 Kaneka Eurogentec S.A Company Information
  141. 8.24.2 Kaneka Eurogentec S.A Business Overview
  142. 8.24.3 Kaneka Eurogentec S.A ELISA Testing Service Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Kaneka Eurogentec S.A ELISA Testing Service Product Portfolio
  144. 8.24.5 Kaneka Eurogentec S.A Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst